Physician profile
Luis M Reyes
NPI 1427027804
$19,929.20
in general payments reported to CMS, 2019-2025
28 companies · $2,819 in 2025
The $2,819 reported for 2025 was more than what 85% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $675 · 2020: $828 · 2021: $9,988 · 2022: $1,360 · 2023: $2,730 · 2024: $1,528 · 2025: $2,819.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,872 · Travel and Lodging: $2,197 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,871.57 |
| Travel and Lodging | $2,197.25 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,569.77 | 2020-2025 | |
| Cvrx, INC. | $1,783.08 | 2025 | Barostim Neo System |
| W. L. Gore & Associates, INC. | $1,616.01 | 2023 | Seamguard, Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Medtronic, INC. | $1,109.86 | 2022-2024 | Signia, Sonicision, Endoflip |
| Covidien LP | $1,015.85 | 2019-2020 | |
| Davol INC. | $769.27 | 2021-2025 | Phasix Mesh |
| Smith+Nephew, INC. | $471.96 | 2021-2025 | Grafix Pl, Stravix, Grafix |
| Ethicon US, LLC | $466.33 | 2021-2024 | Echelon; Endopath, Enseal, Stratafix |
| Novo Nordisk INC | $399.28 | 2023-2025 | Wegovy |
| Teleflex LLC | $253.74 | 2023-2024 | Arrow, Titan Sgs Standard Gastric Stapler |
| Solventum Corporation | $198.68 | 2025 | V.A.C. Veraflo, Prevena |
| Pacira Pharmaceuticals Incorporated | $158.68 | 2021-2023 | Exparel |
| Abbott Laboratories | $146.04 | 2025 | Aveir |
| Reshape Lifesciences INC. | $140.22 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $132.13 | 2022-2023 | Gattex |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $123.02 | 2019 | |
| Lexington Medical, INC. | $120.98 | 2022 | |
| Baxter Healthcare | $120.23 | 2019 | |
| Portola Pharmaceuticals, LLC | $109.16 | 2019 | |
| Urgo Medical North America, LLC | $55.17 | 2024-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Innocoll Pharmaceuticals Limited | $44.39 | 2021-2022 | |
| Redhill Biopharma INC. | $28.13 | 2022-2023 | |
| Melinta Therapeutics, LLC | $25.64 | 2023 | Kimyrsa |
| Phathom Pharmaceuticals, INC. | $20.20 | 2025 | Voquezna |
| Cumberland Pharmaceuticals, INC. | $19.81 | 2019 | |
| Tela Bio, INC. | $14.49 | 2022 | |
| Convatec INC. | $12.86 | 2023 | |
| Rare Disease Therapeutics, INC. | $4.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Reyes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.